With regard to that particular vaccine, there are two separate processes.
The first was a research agreement with Dalhousie University and CanSino, which was a result of the scientific collaboration between CanSino and the NRC. That happened before the task force.
Second, CanSino, along with all the other international vaccines, was considered a potential candidate.
Roger, would you have anything to add to that in terms of detail?